loadpatents
Patent applications and USPTO patent grants for Martinez-Alsina; Luis Angel.The latest application filed is for "novel imidazo[4,5-c]quinoline derivatives as lrrk2 inhibitors".
Patent | Date |
---|---|
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Grant 11,312,713 - Brodney , et al. April 26, 2 | 2022-04-26 |
Novel Imidazo[4,5-c]quinoline Derivatives As Lrrk2 Inhibitors App 20210355117 - BRODNEY; Michael Aaron ;   et al. | 2021-11-18 |
Cyclic substituted imidazo[4,5-c]quinoline derivatives Grant 11,161,844 - Chappie , et al. November 2, 2 | 2021-11-02 |
BCKDK inhibitors Grant 11,059,833 - Bhattacharya , et al. July 13, 2 | 2021-07-13 |
Bckdk Inhibitors App 20210087204 - Bhattacharya; Samit Kumar ;   et al. | 2021-03-25 |
Bckdk Inhibitors App 20210024536 - Bhattacharya; Samit Kumar ;   et al. | 2021-01-28 |
Cyclic Substituted Imidazo[4,5-c]quinoline Derivatives App 20200039977 - Chappie; Thomas Allen ;   et al. | 2020-02-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.